Monomer Bio

Monomer Bio

Biotechnology Research

Pacifica, CA 1,113 followers

Scaling cell biology with data-centric automation software

About us

Founded in 2021 and based in San Francisco, Monomer Bio specializes in wet-lab productivity and automation software built for cell biology workflows. We aim to transform the landscape of scientific research by automating laboratory processes while capturing clean, well-structured data. We have delivered a number of automated cell culture solutions to customers working in the fields of drug discovery and cell and gene therapy. We also consult: whether you need help deciding what instruments to buy, need help getting your instruments and software to talk to each other, or need something custom-built (software or hardware), drop us a note at [email protected]. We love deep dives with your biologists, engineers, technicians, or executive team.

Website
https://monomerbio.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Pacifica, CA
Type
Privately Held
Founded
2021

Locations

Employees at Monomer Bio

Updates

  • Monomer Bio reposted this

    🎄 𝐅𝐨𝐨𝐝 𝐅𝐨𝐫 𝐓𝐡𝐨𝐮𝐠𝐡𝐭 𝐅𝐨𝐫 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬 𝐈𝐧 𝐂𝐞𝐥𝐥 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠. 𝐇𝐚𝐩𝐩𝐲 𝐇𝐨𝐥𝐢𝐝𝐚𝐲𝐬! 🎄 Looking to dive into something inspiring over the holiday break? Check out the new "𝐎𝐮𝐫 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧" section on our website: --> https://hubs.la/Q030wHPs0 Here we describe the 𝐟𝐨𝐮𝐫 𝐩𝐢𝐥𝐥𝐚𝐫𝐬 of our decision-making system for 𝐜𝐥𝐨𝐬𝐞𝐝 𝐥𝐨𝐨𝐩 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞: --> 𝐌𝐨𝐧𝐢𝐭𝐨𝐫 --> 𝐑𝐞𝐜𝐨𝐫𝐝 --> 𝐈𝐧𝐭𝐞𝐫𝐩𝐫𝐞𝐭 --> 𝐀𝐜𝐭 These features are designed to let you 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝙚𝙖𝙧𝙡𝙮. 𝑾𝒉𝒊𝒍𝒆 𝐲𝐨𝐮 𝐠𝐫𝐨𝐰 𝐜𝐞𝐥𝐥𝐬, not after the fact. All the while, we 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞𝐥𝐲 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐝 𝐝𝐚𝐭𝐚𝐬𝐞𝐭𝐬 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐜𝐞𝐥𝐥 𝐥𝐢𝐧𝐞𝐬 𝐚𝐧𝐝 𝐭𝐡𝐞𝐢𝐫 𝐥𝐢𝐧𝐞𝐚𝐠𝐞. 🚀 Perfect for anyone curious about smarter labs, AI, and the future of cell biology. Let us know your thoughts in the comments. Happy holidays! 🎄 #HolidayReading #CellCulture #Automation #DecisionMaking #Innovation #smarterlabs #TechBio

    • No alternative text description for this image
  • 👔 Monomer Bio @ 𝐉𝐏𝐌 𝟐𝟎𝟐𝟓  👔 Our CEO, Jimmy Sastra, PhD will be attending the 2025 𝐉𝐏𝐌𝐨𝐫𝐠𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞. 📍𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨 🗓️  𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝟏𝟑-𝟏𝟔𝐭𝐡, 𝟐𝟎𝟐𝟓. 🤝 Monomer Bio 𝐢𝐬 𝐥𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬🤝 To implement 𝐡𝐢𝐠𝐡 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐩𝐮𝐭 𝐢𝐦𝐚𝐠𝐞-𝐛𝐚𝐬𝐞𝐝 𝐜𝐞𝐥𝐥 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 🧫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐦𝐨𝐝𝐞𝐥𝐢𝐧𝐠 (𝟐𝐃/𝟑𝐃) 🌱 𝐒𝐭𝐞𝐦 𝐜𝐞𝐥𝐥 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐭𝐢𝐨𝐧 ⚙️ 𝐂𝐞𝐥𝐥 𝐋𝐢𝐧𝐞 𝐞𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠 Come find us in the One-on-One Partnering Portal: https://hubs.la/Q030yTcg0 Or schedule a time directly: https://hubs.la/Q030yM2b0 #JPM2025 #drugdiscovery #pharma #diseasemodeling #stemcelldifferentiation #cellengineering

    BIO Partnering @JPM Week | January 13-16, 2025 | San Francisco Marriott Marquis & Virtual

    BIO Partnering @JPM Week | January 13-16, 2025 | San Francisco Marriott Marquis & Virtual

    bpjw.bio.org

  • Monomer Bio reposted this

    View profile for Denise Williams, graphic

    Account Executive Monomer Bio

    ✨Today Monomer Bio is excited to highlight new 𝐢𝐦𝐚𝐠𝐞 𝐯𝐢𝐞𝐰𝐢𝐧𝐠 features in our 𝐂𝐮𝐥𝐭𝐮𝐫𝐞 𝐌𝐨𝐧𝐢𝐭𝐨𝐫 to let you 𝐪𝐮𝐢𝐜𝐤𝐥𝐲 𝐫𝐞𝐯𝐢𝐞𝐰 𝐦𝐚𝐧𝐲 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞𝐬. See below for an update directly from our software team. Whether your differentiating stem cells, growing organoids, or engineering cell lines, ping me if you’re interested in learning more!

    Jon S. on LinkedIn: Super excited to release Monomer’s new image viewing experience! 🎁 I’ve…

    Jon S. on LinkedIn: Super excited to release Monomer’s new image viewing experience! 🎁 I’ve…

    linkedin.com

  • Monomer Bio reposted this

    I recently became a board member at LRIG Bay Area Chapter. My first contribution is organizing 𝐋𝐑𝐈𝐆 𝐁𝐚𝐲 𝐀𝐫𝐞𝐚’𝐬 𝐟𝐢𝐫𝐬𝐭 𝐞𝐯𝐞𝐫 𝐞𝐧𝐝 𝐨𝐟 𝐲𝐞𝐚𝐫 𝐬𝐨𝐜𝐢𝐚𝐥 𝐞𝐯𝐞𝐧𝐭. Please don’t be shy and come say hi. We can chat about our lab robotics interests. Hope to see you there! 📅 Date: December 12th ⏰ Time: 6:00 – 8:00 PM 📍 Location: 1440 Stanford Ave, Emeryville, CA – 94068 🚗 Parking: 5764 Peladeau St (Ginkgo parking spots) 🔗 Sign up: See below!

    LRIG Bay Area Chapter on LinkedIn: #lrig #networkingevent #bayarea #lifesciences #labautomation…

    LRIG Bay Area Chapter on LinkedIn: #lrig #networkingevent #bayarea #lifesciences #labautomation…

    linkedin.com

  • Monomer Bio reposted this

    📣 Big announcement from our customer E11 Bio today!!! See Andrew Payne's post below where he reveals some of their beautiful brain connectome data and puts forth their ambitious roadmap to 𝐬𝐜𝐚𝐥𝐞 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐨𝐦𝐢𝐜𝐬 𝐭𝐨 𝐞𝐧𝐭𝐢𝐫𝐞 𝐦𝐚𝐦𝐦𝐚𝐥𝐢𝐚𝐧 𝐛𝐫𝐚𝐢𝐧𝐬. What sequencing technology did for mapping the human genome 🧬, E11 Bio's PRISM platform will do for mapping the human brain connectome 🧠.

    View profile for Andrew Payne, graphic

    Co-Founder & CEO, E11 Bio

    E11 Bio is excited to share a major step towards brain mapping at 100x lower cost, making whole-brain connectomics at human & mouse scale feasible (🧠→🔬→💻). Critical for curing brain disorders, building human-like & aligned AI systems, and even simulating human brains. E11 Bio’s mission is to unlock connectomics at the scale of whole mammalian brains, first for mice, then for humans. We want to make connectomics radically cheaper and more accessible: here’s how we’re doing it: https://lnkd.in/gAvHDbUE The big challenge for scaling up connectomics is proofreading the output of the AI models used to automatically reconstruct the connectome from large brain image datasets. These AI models are good, but still make many errors which must be manually fixed by human annotators, which makes up 95% of costs. AI will improve, but it will need more and better data to do so. Our PRISM technology addresses this bottleneck by making the neurons “self-annotating.” Each cell makes a different combination of proteins which function as a cellular ID (barcode), giving neurons the potential to proofread themselves. We acquire image datasets of these cells using expansion microscopy and protein staining, and then analyze them using “self-proofreading” AI models we’ve developed to leverage barcodes for reduced human proofreading and lower costs. We still have much work to do in order to scale up PRISM connectomics to large volumes or an entire mouse brain. But by addressing the biggest cost bottlenecks, an optical mouse connectome could come sooner than expected — we predict it could happen in just five years. E11 Bio is a non-profit Focused Research Organization. In line with our open science philosophy, we are rapidly sharing these first details ahead of our initial preprint in 2025, which will document a pilot study as well as a beta version of our methods and AI models. What we plan to do after that is to periodically release increasingly large-scale connectomic data drops and demonstrate increasing performance of our AI models. We are seeking partners in scaled imaging, compute, and data storage as well as automation and instrumentation, and are eager to discuss potential applications of our tools and datasets for AI, biomedicine and other key commercial applications – please reach out if you’re interested! The hippocampal study was a collaborative effort between E11 Bio and Rosa Park (now at E11 Bio) and Sam Rodriques at the Crick Institute, Joergen Kornfeld at Max Planck/LMB Cambridge UK, and Bobae An, Daniel Leible, and Ed Boyden at MIT and HHMI. We are incredibly grateful to E11 Bio’s funders including Eric and Wendy Schmidt, James Fickel, and others. Here’s the link to the roadmap again if you read to the end: https://lnkd.in/gAvHDbUE We hope you will join us in our mission to map the mouse connectome (and beyond!)

  • Monomer Bio reposted this

    Wow wow wow! I'm always really inspired by Science's technologies. I'm 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 excited about the 𝐛𝐢𝐨𝐡𝐲𝐛𝐫𝐢𝐝 𝐧𝐞𝐮𝐫𝐚𝐥 𝐢𝐧𝐭𝐞𝐫𝐟𝐚𝐜𝐞𝐬 𝐜𝐨𝐦𝐛𝐢𝐧𝐢𝐧𝐠 𝐦𝐢𝐜𝐫𝐨𝐜𝐡𝐢𝐩 𝐞𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜𝐬 𝐚𝐧𝐝 𝐥𝐢𝐯𝐢𝐧𝐠 𝐜𝐞𝐥𝐥𝐬 they're reporting on in this video. I still got to hands-on bring up their first 𝐫𝐨𝐛𝐨𝐭𝐢𝐜 𝐰𝐨𝐫𝐤𝐜𝐞𝐥𝐥 𝐟𝐨𝐫 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥-𝐝𝐞𝐫𝐢𝐯𝐞𝐝 𝐧𝐞𝐮𝐫𝐨𝐧𝐬 together with Mark Zhang and Carter Allen in the early days of Monomer Bio. After seeing Alan Mardinly's initial operations get up and running, it's very gratifying to see where they have taken it and what they've accomplished now!

    View organization page for Science, graphic

    4,729 followers

    Today we are unveiling our latest technology: "At Science, we’re developing a biohybrid probe technology using highly engineered, stem cell-derived neurons embedded in vitro in electronics and engrafted into the brain, forming new biological connections. The basic idea is pretty simple: since the brain is already largely composed of neurons, what happens if we add more neurons? The answer is they grow in and wire up extensively. Importantly, we solve the central problem (the destruction of neurons by traditional wire like probes) by keeping the cell bodies with us, which is possible because we started with them. Only their axons and dendrites grow out into the brain, joining the representations they encounter." https://lnkd.in/gYgJzkdB You can take a behind the scenes look into our work thanks to the incredible work of Jason Carman and S3: https://lnkd.in/gA6M_bXZ

    Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities | Science Corporation

    Biohybrid neural interfaces: an old idea enabling a completely new space of possibilities | Science Corporation

    science.xyz

  • Monomer Bio reposted this

    ✨ At Monomer, we're deeply grateful to our customers—heroes on the front lines tackling humanity's greatest challenges: 🧬 𝐂𝐮𝐫𝐢𝐧𝐠 𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 🧫 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐞𝐦𝐛𝐫𝐲𝐨𝐧𝐢𝐜 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 🧠 𝐌𝐚𝐩𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐡𝐮𝐦𝐚𝐧 𝐛𝐫𝐚𝐢𝐧 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐨𝐦𝐞 ⏳ 𝐓𝐚𝐦𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐫𝐚𝐠𝐨𝐧-𝐭𝐲𝐫𝐚𝐧𝐭 𝐨𝐟 𝐚𝐠𝐢𝐧𝐠 Our mission is bold: to create groundbreaking tools that unlock the mysteries of living cells, pushing the boundaries of what's possible. By innovating with purpose, we aim to cure diseases and inspire the world with new insights into the intricate workings of life. To our customers: thank you for your relentless dedication and vision. Together, we're shaping the future of science and making the impossible, possible. 🚀 #Innovation #LifeSciences #Gratitude #MonomerMission

  • Monomer Bio reposted this

    🚨 Pharma R&D costs are climbing while returns shrink, threatening the sustainability of drug discovery. According to Deloitte, average R&D costs per asset have jumped by 76% over the past decade, while forecasted peak sales per asset dropped by 30% between 2013 and 2023. This trajectory is unsustainable. 💡 𝘛𝘦𝘤𝘩𝘉𝘪𝘰 𝘤𝘰𝘶𝘭𝘥 𝘣𝘦 𝘵𝘩𝘦 𝘢𝘯𝘴𝘸𝘦𝘳. TechBio can scale up experiments and eliminate candidates early, by leveraging: 1. 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐛𝐢𝐨𝐥𝐨𝐠𝐲 – Moving from small molecules to biologics and cell therapies is transforming therapeutic possibilities. Increasingly complex disease models generate more accurate results. 2. 𝐏𝐫𝐨𝐥𝐢𝐟𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐥𝐚𝐛 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 – Enables high throughput to explore broader solution spaces. 3. 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 𝐨𝐟 𝐦𝐚𝐜𝐡𝐢𝐧𝐞 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠 – With some models now surpassing human performance, ML is guiding smarter, faster decisions. The industry talks a lot about AI in labs. In this recent talk, I introduced a framework for talking about the different levels of lab intelligence: - 𝗟𝗲𝘃𝗲𝗹 𝟱: Artificial General Intelligence - 𝗟𝗲𝘃𝗲𝗹 𝟰: Autonomous - 𝗟𝗲𝘃𝗲𝗹 𝟯: ML-Guided - 𝗟𝗲𝘃𝗲𝗹 𝟮: Data-Centric - 𝗟𝗲𝘃𝗲𝗹 𝟭: Automated - 𝗟𝗲𝘃𝗲𝗹 𝟬: Manual 📽️ Interested in learning more? Comment below for a copy of my slides, or watch the 𝗗𝗔𝗬 𝟮 recording here: https://hubs.la/Q02Y6_vb0 #PharmaInnovation #TechBio #DrugDiscovery #MachineLearning #Automation #Biotech #FutureOfMedicine

    • No alternative text description for this image

Similar pages

Funding

Monomer Bio 1 total round

Last Round

Seed

US$ 5.6M

See more info on crunchbase